Litigation
Aug. 8, 2013
Toyota's defense in acceleration trial to center on blood sugar level
A centerpiece of Toyota Motor Corp.'s defense in an upcoming trial over the carmaker's acceleration problems appears to be the blood sugar level of crash victim Noriko Uno, according to court filings.
Daily Journal Staff Writer
A centerpiece of Toyota Motor Corp.'s defense in an upcoming trial over the carmaker's acceleration problems appears to be the blood sugar level of crash victim Noriko Uno, according to court filings.
Attorneys for Toyota and a driver who hit Uno before her fatal accident plan to argue in the bellwether sudden unintended acceleration trial that the 66-year-old Upland woman's low blood sug...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In